Home LiteratureArticle Details
PMID: 25879744 Published · epublish English Historical Article Journal Article Research Support, Non-U.S. Gov't

International trends in primary liver cancer incidence from 1973 to 2007.

BMC cancer ·Vol. 15 ·2015-03-04 ·Pages 94

Zhang Y, Ren JS, Shi JF, Li N, Wang YT, Qu C, Zhang Y, Dai M

Abstract

Primary liver cancer (PLC) is a common cancer worldwide, especially in developing countries. Several previous studies using different datasets have summarized PLC incidence rates and trends in different populations. However, with changes in exposure to risk factors and the implementation of preventive measures, the epidemiology of PLC worldwide may have changed. We extended the analyses using the latest data from Cancer Incidence in Five Continents over the 35-year period 1973-2007 from 24 populations in Americas, Asia, Europe and Oceania using Joinpoint regression analysis. We examined age-standardized rates (ASRs) of PLC by histologic subtypes for both males and females in 24 populations during the period 2003-2007. We found that during the period 2003-2007, the highest ASRs for PLC were observed in some Asian populations, ranging from 19.0 to 26.7 per 100,000 in males and 4.8 to 8.7 per 100,000 in females. The international trends between 1973 and 2007 showed that ASRs for PLC were declining in several Asian populations. In contrast, ASRs for PLC were increasing in some European, American and Oceanian populations. Although the reasons were not fully clear for these trends, public health measures in Asian populations and HCV transmission in European, American and Oceanian populations were likely to have contributed to these patterns. Meanwhile, other possible risk factors such as the consumption of alcohol, obesity, and nonalcoholic fatty liver disease should also be concerned for the burden of PLC.

MeSH Terms
Age Factors Datasets as Topic Female Global Health History, 20th Century History, 21st Century Humans Incidence Liver Neoplasms/epidemiology,history Male Population Surveillance Sex Factors
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Zhang Yue
National Office for Cancer Prevention and Control, Cancer Institute & Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100021, China. zhangyue222@yeah.net.
Ren Jian-Song
National Office for Cancer Prevention and Control, Cancer Institute & Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100021, China. renjiansong@sina.com.
Shi Ju-Fang
National Office for Cancer Prevention and Control, Cancer Institute & Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100021, China. shijf@cicams.ac.cn.
Li Ni
National Office for Cancer Prevention and Control, Cancer Institute & Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100021, China. lini1240@hotmail.com.
Wang Yu-Ting
State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, China. wyt2051@163.com.
Qu Chunfeng
State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, China. quchf@cicams.ac.cn.
Zhang Yawei
National Office for Cancer Prevention and Control, Cancer Institute & Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100021, China. yawei.zhang@yale.edu. | Yale School of Public Health, Yale School of Medicine, Yale Cancer Center, New Haven, CT, 06510, USA. yawei.zhang@yale.edu.
Dai Min
National Office for Cancer Prevention and Control, Cancer Institute & Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100021, China. daiminlyon@gmail.com.
References (35)
35 references, click to expand
  1. Cancer incidence trends in urban shanghai, 1972-1994: an update.
    Int J Cancer. 1999 Nov 12;83(4):435-40 PMID: 10508476
  2. Rising incidence of hepatocellular carcinoma in the United States.
    N Engl J Med. 1999 Mar 11;340(10):745-50 PMID: 10072408
  3. Alcohol and liver cancer.
    Eur J Cancer Prev. 2007 Dec;16(6):495-7 PMID: 18090120
  4. Incidence of primary liver cancer in Italy between 1988 and 2002: an age-period-cohort analysis.
    Eur J Cancer. 2008 Jan;44(2):285-92 PMID: 18155898
  5. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003.
    Ann Intern Med. 2008 Jun 3;148(11):820-6 PMID: 18519928
  6. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.
    Vaccine. 2009 Nov 5;27(47):6550-7 PMID: 19729084
  7. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.
    Cancer Lett. 2009 Dec 1;286(1):9-14 PMID: 19091458
  8. Changing trends in hepatitis C infection over the past 50 years in Japan.
    Intervirology. 2010;53(1):39-43 PMID: 20068339
  9. The changing pattern of epidemiology in hepatocellular carcinoma.
    Dig Liver Dis. 2010 Jul;42 Suppl 3:S206-14 PMID: 20547305
  10. Global patterns of cancer incidence and mortality rates and trends.
    Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1893-907 PMID: 20647400
  11. Hepatocellular carcinoma.
    N Engl J Med. 2011 Sep 22;365(12):1118-27 PMID: 21992124
  12. International trends in liver cancer incidence rates.
    Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2362-8 PMID: 21921256
  13. Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005.
    Eur J Epidemiol. 2012 Jan;27(1):39-46 PMID: 22160277
  14. Epidemiology of viral hepatitis and hepatocellular carcinoma.
    Gastroenterology. 2012 May;142(6):1264-1273.e1 PMID: 22537432
  15. Influences of tobacco and alcohol use on hepatocellular carcinoma survival.
    Int J Cancer. 2012 Dec 1;131(11):2612-21 PMID: 22362517
  16. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China.
    Carcinogenesis. 2013 Aug;34(8):1800-5 PMID: 23322152
  17. Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.
    JAMA. 2013 Sep 4;310(9):974-6 PMID: 24002285
  18. Behavioral and dietary risk factors for noncommunicable diseases.
    N Engl J Med. 2013 Sep 5;369(10):954-64 PMID: 24004122
  19. Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review.
    Vaccine. 2013 Dec 17;32(1):103-10 PMID: 24200974
  20. Cancer survival in China, 2003-2005: a population-based study.
    Int J Cancer. 2015 Apr 15;136(8):1921-30 PMID: 25242378
  21. Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988-2010.
    Eur J Cancer. 2015 Jun;51(9):1144-63 PMID: 24269041
  22. A prospective study of obesity and cancer risk (Sweden).
    Cancer Causes Control. 2001 Jan;12(1):13-21 PMID: 11227921
  23. International trends and patterns of primary liver cancer.
    Int J Cancer. 2001 Oct 15;94(2):290-6 PMID: 11668511
  24. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women.
    Am J Epidemiol. 2002 Feb 15;155(4):323-31 PMID: 11836196
  25. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future.
    Oncology. 2002;62 Suppl 1:8-17 PMID: 11868791
  26. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.
    N Engl J Med. 2003 Apr 24;348(17):1625-38 PMID: 12711737
  27. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.
    Hepatology. 2003 May;37(5):1202-19 PMID: 12717402
  28. Primary liver cancer: worldwide incidence and trends.
    Gastroenterology. 2004 Nov;127(5 Suppl 1):S5-S16 PMID: 15508102
  29. Incidence of primary liver cancer in Singapore, 1968-1982.
    Ann Acad Med Singapore. 1989 May;18(3):313-6 PMID: 2549842
  30. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.
    Hepatology. 1990 Oct;12(4 Pt 1):671-5 PMID: 2170265
  31. Obesity and cancer risk: a Danish record-linkage study.
    Eur J Cancer. 1994;30A(3):344-50 PMID: 8204357
  32. Liver cancer and its prevention.
    Asian Pac J Cancer Prev. 2005 Jul-Sep;6(3):244-50 PMID: 16235981
  33. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.
    J Gastrointest Surg. 2006 Jul-Aug;10(7):987-98 PMID: 16843869
  34. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.
    Gastroenterology. 2007 Jun;132(7):2557-76 PMID: 17570226
  35. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies.
    Br J Cancer. 2007 Oct 8;97(7):1005-8 PMID: 17700568
Article Info
Journal
BMC cancer
Abbr.
BMC Cancer
ISSN
1471-2407
Published
2015-03-04
Epub
2015-00-04
Pages
94
Language
English
Region
England
NLM ID
100967800
PMCID
PMC4359785
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com